Youssef M.K. Farag

机构：Harvard University, Johns Hopkins University, Bayer (United States), AstraZeneca (Brazil), Alexion Pharmaceuticals (United States), AstraZeneca (United States), Alexion Pharma (Switzerland) · ORCID：0000-0003-1692-1851

发表论文 48 篇 · 总被引 844 次 · h-index 10

代表论文

• Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes (2023 · Annals of Internal Medicine · 被引 95)
• Clinical trial designs of emerging therapies for diabetic kidney disease (DKD) (2024 · Postgraduate Medicine · 被引 8)
• Anemia, CKD, and Cognitive Function: The National Health and Nutrition Examination Survey (2024 · Kidney360 · 被引 8)
• Impact of Preoperative Weight Loss on 30-Day Complication Rate after Bariatric Surgery (2024 · Journal of the American College of Surgeons · 被引 8)
• Plasma Ferritin Levels, Incident Heart Failure, and Cardiac Structure and Function (2024 · JACC Heart Failure · 被引 7)
• A FIDELITY Analysis on Finerenone With SGLT-2i and GLP-1RA in CKD (2025 · Kidney International Reports · 被引 6)